First Quadrant’s Amedisys AMED Stock Holding History

First Quadrant’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,918	Closed	-$382K	–	569
2019 Q3	$382K	Sell	2,918 -3,641	-56%	-$474K	0.04%	345
2019 Q2	$796K	Sell	6,559 -1,441	-18%	-$171K	0.06%	336
2019 Q1	$986K	Sell	8,000 -4,116	-34%	-$517K	0.08%	267
2018 Q4	$1.42M	Buy	12,116 +4,598	+61%	+$542K	0.11%	184
2018 Q3	$939K	Buy	+7,518	New	+$830K	0.02%	395
2016 Q2	–	Sell	-31,600	Closed	-$1.53M	–	806
2016 Q1	$1.53M	Buy	31,600 +22,400	+243%	+$864K	0.03%	343
2015 Q4	$362K	Buy	9,200 +9,000	+4,500%	+$360K	0.01%	508
2015 Q3	$8K	Buy	+200	New	+$8.44K	﹤0.01%	774

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

First Quadrant's AMED Position: Q4 2019 in Review

First Quadrant sold out of Amedisys (AMED) in Q4 2019, closing a stake of 2,918 shares — an estimated $382K sold.

First Quadrant first reported a position in AMED in Q3 2015 and held it in 8 quarters. The position peaked at $1.53M in Q1 2016. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

First Quadrant reported no remaining Amedisys position as of Q4 2019 after selling out during the quarter.
First Quadrant sold 2,918 Amedisys shares in Q4 2019, an estimated $382K.
First Quadrant first reported a position in Amedisys in Q3 2015 and held it in 8 quarters.
First Quadrant's Amedisys position peaked at $1.53M in Q1 2016.
325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on First Quadrant's 13F filing for Q4 2019, filed 28 Jan 2020.